Skip to main content
. 2017 Aug 1;56(16):2119–2123. doi: 10.2169/internalmedicine.8398-16

Table 2.

A Summary of the Semi-structured Interviews.

Number of
patients
Age
(mean±SD)
Wheelchair Acceptance of
SMON disease
Comorbidity
of cancer
Single
life
Social
activity
Aggravation group 6 80.0±5.5 67%* 50%* 33% 33% 33%*
Non-aggravation group 13 77.5±7.0 15% 100% 31% 15% 92%

Asterisks indicate a significant difference between the aggravation and non-aggravation groups (Fisher’s exact test).